24. Lehman T. J. A., Allen J. B., Plotz P. H. and Wilder R. L. (1984) Lactobacillus casei cell wall-induced arthritis in rats:
cell wall fragment distribution and persistence in chronic arthritis-susceptible LEW/N and -resistant F344/N rats. Arth.
Rheum. 27, 939–942.
25. Lepore M., Liu X., Savage V., Matalon D. and Gardner E. L. (1996) Genetic diVerences in ~9-tetrahydrocannabinolinduced facilitation of brain stimulation reward as measured by a rate–frequency curve-shift electrical brain
stimulation paradigm in three diVerent rat strains. Life Sci. 58, 365–372.
26. Matsunaga E., Zanger U. M., Hardwick J. P., Gelboin H. V., Meyer U. A. and Gonzalez F. J. (1989) The CYP2D
gene subfamily: analysis of the molecular basis of the debrisoquine 4-hydroxylase deficiency in DA rats. Biochemistry
28, 7349–7355.
27. Nestler E. J., Erdos J. J., Terwilliger R. Z., Duman R. S. and Tallman J. F. (1989) Regulation of G-proteins by chronic
morphine treatment in the rat locus coeruleus. Brain Res. 476, 230–239.
28. Nestler E. J., Hope B. T. and Widnell K. L. (1993) Drug addiction: a model for the molecular basis of neural plasticity.
Neuron 11, 995–1006.
29. Nestler E. J. and Tallman J. F. (1988) Chronic morphine treatment increases cyclic AMP-dependent protein kinase
activity in the rat locus coeruleus. Molec. Pharmac. 33, 127–132.
30. Nestler E. J., Terwilliger R. Z., Walker J. R., Sevarino K. A. and Duman R. S. (1990) Chronic cocaine treatment
decreases levels of the G-protein subunits GiÆ and GoÆ in discrete regions of rat brain. J. Neurochem. 55, 1079–
1082.
31. Oitzl M. S., van Haarst A. D., Sutanto W. and de Kloet E. R. (1995) Corticosterone, brain mineralocorticoid receptors
(MRs) and the activity of the hypothalamic–pituitary–adrenal (HPA) axis: the Lewis rat as an example of increased
central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 20, 655–675.
32. Ortiz J., DeCaprio J. L., Kosten T. A. and Nestler E. J. (1995) Strain-selective eVects of corticosterone on locomotor
sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area.
Neuroscience 67, 383–397.
33. Ortiz J., Fitzgerald L. W., Lane S., Terwilliger R. and Nestler E. J. (1996) Biochemical adaptations in the mesolimbic
dopamine system in response to repeated stress. Neuropsychopharmacology 14, 443–452.
34. Piazza P. V., Deminiere J.-M., Le Moal M. and Simon H. (1989) Factors that predict individual vulnerability to
amphetamine self-administration. Science 245, 1511–1513.
35. Piazza P. V. and Le Moal M. (1996) Pathophysiological basis of vulnerability to drugs of abuse: role of an interaction
between stress, glucocorticoids, and dopaminergic neurons. A. Rev. Pharmac. Toxic. 36, 359–378.
36. Prasad B. M., Ulibarri C., Kalivas P. W. and Sorg B. A. (1996) EVect of adrenalectomy on the initiation and
expression of cocaine-induced sensitization. Psychopharmacology 125, 265–273.
37. Remmers E. F., Longman R. E., Du Y., O'Hare A., Cannon G. W., GriYths M. M. and Wilder R. L. (1996) A
genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats. Nature Genet. 14, 82–85.
38. Rouge-Pont F., Marinelli M., Le Moal M., Simon H. and Piazza P. V. (1995) Stress-induced sensitization and
glucocorticoids. II. Sensitization of the increase in extracellular dopamine induced by cocaine depends on stressinduced corticosterone secretion. J. Neurosci. 15, 7189–7195.
39. Sarnyai Z., Mello N. K., Mendelson J. H., Eros-Sarnyai M. and Mercer G. (1996) EVects of cocaine on pulsatile
activity of hypothalamic–pituitary–adrenal axis in male rhesus monkeys: neuroendocrine and behavioral correlates.
J. Pharmac. exp. Ther. 277, 225–234.
40. Sternberg E. M., Glowa J. R., Smith M. A., Calogero A. E., Listwak S. J., Aksentijevich S., Chrousos G. P., Wilder
R. L. and Gold P. W. (1992) Corticotropin releasing hormone related behavioral and neuroendocrine responses to
stress in Lewis and Fischer rats. Brain Res. 570, 54–60.
41. Suzuki T., George F. R. and Meisch R. A. (1988) DiVerential establishment and maintenance of oral ethanol
reinforced behavior in Lewis and Fischer 344 inbred rat strains. J. Pharmac. exp. Ther. 245, 164–170.
42. Suzuki T., Otani K., Koike Y. and Misawa M. (1988) Genetic diVerences in preferences for morphine and codeine in
Lewis and Fischer 344 inbred rat strains. Jpn. J. Pharmac. 47, 425–431.
43. Terwilliger R. Z., Beitner-Johnson D., Sevarino K. A., Crain S. M. and Nestler E. J. (1991) A general role for
adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on
neuronal function. Brain Res. 548, 100–110.
44. Van Eekelen J. A., Oitzl M. S. and De Kloet E. R. (1995) Adrenocortical hyporesponsiveness and glucocorticoid
feedback resistance in old male brown Norway rats. J. Geront. A, Biol. Sci. med. Sci. 50, B83–B89.
45. Wallace J. E., Harris S. C. and Peek M. W. (1980) Determination of morphine by liquid chromatography with
electrochemical detection. Analyt. Chem. 52, 1328–1330.
46. Wilder R. L., Calandra G. B., Garvin A. J., Wright K. D. and Hansen C. T. (1982) Strain and sex variation in the
susceptibility to streptococcal cell wall-induced polyarthritis in the rat. Arth. Rheum. 25, 1064–1072.
47. Wise R. A. (1996) Neurobiology of addiction. Curr. Opin. Neurobiol. 6, 243–251.
